Methyl 5-bromo-2-oxoindoline-7-carboxylate

Catalog No.: 
ACYUAS514
CAS No.: 
898747-32-5
Molecular Formula: 
C10H8BrNO3
Molecular Weight: 
270.08
Methyl 5-bromo-2-oxoindoline-7-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$53.00In stockInquiry
1g95%$110.00In stockIn stock
5g95%$357.00In stockIn stock
25g95%$1213.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 5-bromo-2-oxoindoline-7-carboxylate
IUPAC Namemethyl 5-bromo-2-oxoindoline-7-carboxylate
MDL No.MFCD08458993
Molecular FormulaC10H8BrNO3
Molecular Weight270.08
SMILESO=C(C1=CC(Br)=CC2=C1NC(C2)=O)OC
InChI KeyIDAJCGPGSZBXCR-UHFFFAOYSA-N
Synonymmethyl 5-bromo-2-oxoindoline-7-carboxylate | 898747-32-5 | methyl 5-bromo-2-oxo-2,3-dihydro-1H-indole-7-carboxylate | methyl 5-bromo-2-oxo-1,3-dihydroindole-7-carboxylate | MFCD08458993 | Methyl5-bromo-2-oxoindoline-7-carboxylate | 5-Bromo-2-oxyindole-7-carboxylic ac
CAS No.898747-32-5
PubChem CID24728929

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACYUAS514 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYUAS514 route product structure diagram
    ACYUAS514898747-32-5In Stock
Inquiry

2. ACYUAS514 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYUAS514 route product structure diagram
    ACYUAS514898747-32-5In Stock
Inquiry

3. ACYUAS514 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYUAS514 route product structure diagram
    ACYUAS514898747-32-5In Stock
Inquiry

Comments (0)